{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T11:30:43Z","timestamp":1782127843227,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T00:00:00Z","timestamp":1458259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana Ricerca Cancro","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","exphem.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.exphem.2016.03.005","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T03:46:08Z","timestamp":1458618368000},"page":"624-634.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Circulating miRNA panel for prediction of acute graft-versus-host disease in\u00a0lymphoma patients undergoing matched unrelated hematopoietic stem cell\u00a0transplantation"],"prefix":"10.1016","volume":"44","author":[{"given":"Silvia","family":"Gimondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Dugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Vendramin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisa","family":"Bermema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Biancon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Cavan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Carniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2016.03.005_bib1","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.beha.2012.10.010","article-title":"Have we made progress in the treatment of GVHD?","volume":"25","author":"Harris","year":"2012","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.exphem.2016.03.005_bib3","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.bbmt.2010.03.024","article-title":"HLA-allele matched unrelated donors compared to HLA-matched sibling donors: Role of cell source and disease risk category","volume":"16","author":"Woolfrey","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib4","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V75.4.1024.1024","article-title":"Treatment of moderate\/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: An analysis of clinical risk features and outcome","volume":"75","author":"Weisdorf","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1034\/j.1600-0609.2003.00078.x","article-title":"Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation","volume":"70","author":"Remberger","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.exphem.2016.03.005_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bbmt.2008.04.002","article-title":"Plasma elevations of tumor necrosis factor-receptor-1 at day 7 postallogeneic transplant correlate with graft-versus-host disease severity and overall survival in pediatric patients","volume":"14","author":"Kitko","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib7","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1182\/blood-2008-02-138867","article-title":"Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival","volume":"112","author":"Choi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/bmt.2009.360","article-title":"Elevations of tumor necrosis factor receptor 1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning","volume":"45","author":"Willems","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib9","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bbmt.2010.05.001","article-title":"Diarrhea during the conditioning regimen is correlated with the occurrence of severe acute graft-versus-host disease through systemic release of inflammatory cytokines","volume":"16","author":"Liu","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/bmt.2010.165","article-title":"Biomarkers of immune activation to screen for severe, acute GVHD","volume":"46","author":"August","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.bbmt.2009.11.023","article-title":"High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation","volume":"16","author":"Cho","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1182\/blood-2008-07-167098","article-title":"A biomarker panel for acute graft-versus-host disease","volume":"113","author":"Paczesny","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib13","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2011-10-387357","article-title":"Plasma biomarkers of lower gastrointestinal and liver acute GVHD","volume":"119","author":"Harris","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib14","doi-asserted-by":"crossref","first-page":"13ra2","DOI":"10.1126\/scitranslmed.3000406","article-title":"Elafin is a biomarker of graft-versus-host disease of the skin","volume":"2","author":"Paczesny","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.exphem.2016.03.005_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: Target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2016.03.005_bib16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2016.03.005_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.exphem.2016.03.005_bib18","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature03702","article-title":"MicroRNA expression profiles classify human cancers","volume":"435","author":"Lu","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2016.03.005_bib19","doi-asserted-by":"crossref","first-page":"10513","DOI":"10.1073\/pnas.0804549105","article-title":"Circulating microRNAs as stable blood-based markers for cancer detection","volume":"105","author":"Mitchell","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2016.03.005_bib20","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/cr.2008.282","article-title":"Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases","volume":"18","author":"Chen","year":"2008","journal-title":"Cell Res"},{"key":"10.1016\/j.exphem.2016.03.005_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrc1840","article-title":"Oncomirs\u2014MicroRNAs with a role in cancer","volume":"6","author":"Esquela-Kerscher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.exphem.2016.03.005_bib22","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/SLA.0b013e3181cc939f","article-title":"Circulating microRNAs as novel minimally invasive biomarkers for breast cancer","volume":"251","author":"Heneghan","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.exphem.2016.03.005_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gut.2008.167817","article-title":"Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening","volume":"58","author":"Ng","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.exphem.2016.03.005_bib24","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1182\/blood-2013-06-510586","article-title":"Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease","volume":"122","author":"Xiao","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib25","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1182\/blood.V99.1.75","article-title":"Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies","volume":"99","author":"Corradini","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2016.03.005_bib26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1373\/clinchem.2003.028506","article-title":"Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics","volume":"50","author":"El-Hefnawy","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.exphem.2016.03.005_bib27","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1073\/pnas.1100048108","article-title":"MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer","volume":"108","author":"Boeri","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.exphem.2016.03.005_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.2517-6161.1974.tb00994.x","article-title":"Cross-validatory choice and assessment of statistical predictions","volume":"36","author":"Stone","year":"1974","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.exphem.2016.03.005_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A\u00a0practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/j.exphem.2016.03.005_bib30","volume":"Vol 8","author":"Vapnik","year":"1995"},{"key":"10.1016\/j.exphem.2016.03.005_bib31","unstructured":"Meyer D, Dimitriadou E, Hornik K, Weingessel A, Leisch F. Misc functions of the Department of Statistics (e1071), TU Wien. R Package Version 1.6\u20132."},{"key":"10.1016\/j.exphem.2016.03.005_bib32","series-title":"R: A language and environment for statistical computing","first-page":"409","year":"2011"},{"key":"10.1016\/j.exphem.2016.03.005_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1365-2141.2012.09129.x","article-title":"Diagnosis and management of acute graft-versus-host disease","volume":"158","author":"Dignan","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2016.03.005_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/bmt.2009.255","article-title":"Background to hematopoietic cell transplantation, including post transplant immune recovery","volume":"44","author":"Mackall","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib35","first-page":"1","article-title":"Early-phase GVHD gene expression profile in target versus non-target tissues: Kidney, a possible target?","volume":"48","author":"Sadeghi","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/TP.0b013e31816691ef","article-title":"Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host disease","volume":"85","author":"Gannag\u00e9","year":"2008","journal-title":"Transplantation"},{"key":"10.1016\/j.exphem.2016.03.005_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1084\/jem.20101559","article-title":"The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells","volume":"208","author":"Takashima","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2016.03.005_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0057841","article-title":"Dampening enthusiasm for circulating microRNA in breast cancer","volume":"8","author":"Leidner","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.exphem.2016.03.005_bib39","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1007\/s10529-010-0380-z","article-title":"Normalization strategies for microRNA profiling experiments: A \u201cnormal\u201d way to a hidden layer of complexity?","volume":"32","author":"Meyer","year":"2010","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.exphem.2016.03.005_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)","volume":"50","author":"Kroh","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.exphem.2016.03.005_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"10.1016\/j.exphem.2016.03.005_bib42","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1158\/0008-5472.CAN-04-0496","article-title":"Normalization of real-time quantitative reverse transcription-PCR data: A model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets","volume":"64","author":"Andersen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.exphem.2016.03.005_bib43","doi-asserted-by":"crossref","first-page":"R64","DOI":"10.1186\/gb-2009-10-6-r64","article-title":"A novel and universal method for microRNA RT-qPCR data normalization","volume":"10","author":"Mestdagh","year":"2009","journal-title":"Genome Biol"},{"key":"10.1016\/j.exphem.2016.03.005_bib44","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1261\/rna.035055.112","article-title":"The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease","volume":"19","author":"Wu","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.exphem.2016.03.005_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jlb.60.2.159","article-title":"The role of early growth response gene 1 (egr-1) in regulation of the immune response","volume":"60","author":"McMahon","year":"1996","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.exphem.2016.03.005_bib46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10753-011-9390-9","article-title":"Genes differentially regulated by NKX2-3 in B cells between ulcerative colitis and Crohn\u2019s disease patients and possible involvement of EGR1","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.exphem.2016.03.005_bib47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.exphem.2016.03.005_bib48","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.bbmt.2012.01.020","article-title":"Roles of transforming growth factor-\u03b2 in graft-versus-host and graft-versus-tumor effects","volume":"18","author":"Carli","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2016.03.005_bib49","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1111\/jcmm.12625","article-title":"The circulating transcriptome as a source of non-invasive cancer biomarkers: Concepts and controversies of non-coding and coding RNA in body fluids","volume":"19","author":"Fernandez-Mercado","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.exphem.2016.03.005_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ab.2013.03.002","article-title":"Feasibility of circulating miRNA microarray analysis from archival plasma samples","volume":"437","author":"Callari","year":"2013","journal-title":"Anal Biochem"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16300340?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X16300340?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T05:47:43Z","timestamp":1718430463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X16300340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":50,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0301472X16300340"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2016.03.005","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating miRNA panel for prediction of acute graft-versus-host disease in\u00a0lymphoma patients undergoing matched unrelated hematopoietic stem cell\u00a0transplantation","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2016.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}